Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 3 Interventional Results available

Long-term Extension Study of Ligelizumab in Food Allergy

ClinicalTrials.gov ID: NCT05678959

Public ClinicalTrials.gov record NCT05678959. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 22, 2026, 9:44 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Three-year, Multi-center, Double-blind, Extension Study to Evaluate the Long-term Safety and Efficacy of Ligelizumab in Patients Who Completed Ligelizumab's Phase III Studies in Food Allergy

Study identification

NCT ID
NCT05678959
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 3
Lead sponsor
Novartis Pharmaceuticals
Industry
Enrollment
163 participants

Conditions and interventions

Conditions

Interventions

  • Ligelizumab 120 mg Drug
  • Ligelizumab 240 mg Drug

Drug

Eligibility (public fields only)

Age range
6 Years to 57 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Apr 26, 2023
Primary completion
Mar 5, 2025
Completion
Mar 5, 2025
Last update posted
Jan 12, 2026

2023 – 2025

United States locations

U.S. sites
25
U.S. states
18
U.S. cities
24
Facility City State ZIP Site status
Allervie Clinical Research Birmingham Alabama 35209
Allergy and Immunology Associates Scottsdale Arizona 85251
Arkansas Children's Hospital Little Rock Arkansas 72202
Allergy and Asthma Associates of Santa Clara Vally Center San Jose California 95117
Allergy and Asthma Clin Res Inc Walnut Creek California 94598
UCHealth Outpatient Pavilion Aurora Colorado 80045
Asthma and Allergy Associates P C Colorado Springs Colorado 80907
Univ of South Florida Asthma Allergy and Immunology CRU Tampa Florida 33613
Childrens Healthcare of Atlanta Atlanta Georgia 30342
Atlanta Allergy and Asthma Clinic Marietta Georgia 30062
Ann and Robert H Lurie Childs Hosp Chicago Illinois 60611
Family Allergy and Asthma Lousiville Kentucky 40217
Johns Hopkins Childrens Center Baltimore Maryland 21287
Boston Childrens Hospital Boston Massachusetts 02215
University of Michigan Clinical Trials Office Ann Arbor Michigan 48109
Respiratory Medicine Research Institute of Michigan Ypsilanti Michigan 48197
UBMD Pediatrics Buffalo New York 14203
Northwell Health New York New York 10028
Mt Sinai Medical Center New York New York 10029-6574
University Of NC At Chapel Hill Chapel Hill North Carolina 27599 9500
Cincinnati Childrens Hospital MC Cincinnati Ohio 45229-3039
Childrens Hospital Of Philadelphia Philadelphia Pennsylvania 19104
Unv of TX Southwestern Medical Center Dallas Texas 75235
Texas Childrens Hospital Houston Texas 77030
Seattle Allergy and Asthma Rsch Seattle Washington 98115

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 24 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05678959, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jan 12, 2026 · Synced Jul 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT05678959 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →